Contract research organization market expected to reach $113.79 billion by 2031, driven by R&D outsourcing
From GlobeNewswire: 2025-05-07 10:28:00
A new report from The Insight Partners reveals significant growth in the contract research organization market due to increased R&D outsourcing. The market is expected to reach US$ 113.79 billion by 2031, with a CAGR of 8.2%. North America leads, while Asia Pacific shows rapid expansion. Pharmaceutical and biotech firms drive demand, especially in specialized services for biologics and biosimilars.
The contract research organization market is segmented based on service type, product type, application, and end user. Clinical research services and biosimilars lead in their respective segments. The market is also segmented by in-house versus outsource models. Oncology dominates application segments, and pharmaceutical and biotech companies are the largest end users.
Key players in the contract research organization market include Parexel International Corp, Thermo Fisher Scientific, and Medpace Holdings Inc. Trending topics include microbiology CRO services and antibody drug conjugates. The industry thrives on providing cost-effective research solutions, catering to the needs of pharmaceutical, biotech, and medical device companies.
The market is evolving with technological advancements and globalization of clinical trials, driving growth and innovation. Despite challenges around regulatory complexities and data security concerns, the CRO market is poised for sustained expansion. Strategic collaborations and digital integration play key roles in accelerating research and bringing new therapies to market efficiently. Stakeholders can leverage insights from The Insight Partners’ report to navigate the market landscape effectively.
Read more at GlobeNewswire: Contract Research Organization (CRO) Market Set to Surpass